CN105267436A - Drug for treating allergic rhinitis - Google Patents

Drug for treating allergic rhinitis Download PDF

Info

Publication number
CN105267436A
CN105267436A CN201510807822.5A CN201510807822A CN105267436A CN 105267436 A CN105267436 A CN 105267436A CN 201510807822 A CN201510807822 A CN 201510807822A CN 105267436 A CN105267436 A CN 105267436A
Authority
CN
China
Prior art keywords
parts
effective
radix
allergic rhinitis
atractylodis macrocephalae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510807822.5A
Other languages
Chinese (zh)
Inventor
包莉丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510807822.5A priority Critical patent/CN105267436A/en
Publication of CN105267436A publication Critical patent/CN105267436A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a drug for treating allergic rhinitis, made from following medicinal materials by weight: Fructus Xanthii 5 parts, Radix Saposhnikoviae 4 parts, Rhizoma Atractylodis Macrocephalae 5 parts, Herba Oxalidis Corniculatae 3 parts, Radix ET Rhizoma Rhodiolae 2 parts, mint 4 parts, Radix Ilicis Asprellae 3 parts, Exocarpium Citri Grandis 5 parts, and Cortex Lycii Radicis 2 parts. In the application of the drug, Fructus Xanthii is effective in dispelling wind, removing dampness and relieving stuffy nose; Radix Saposhnikoviae is effective in relieving exterior syndrome; Rhizoma Atractylodis Macrocephalae is effective in tonifying spleen and qi and drying dampness to promote diuresis; Herba Oxalidis Corniculatae is effective in tonifying lung and purging liver fire, and eliminating heat and tonifying blood; Radix et Rhizoma Rhodiolae is effective in activating blood to stop bleeding, and removing heat from the lung to relieve cough; mint is effective in repelling foulness and removing toxin; Radix Ilicis Asprellae is effective in encouraging production of body fluids to extinguish thirst; Exocarpium Citri Grandis is effective in dispelling cold and drying dampness; Cortex Lycii Radicis is effective in clearing lung and lowering fire. The herbs combine to be effective in tonifying qi and consolidating superficies, and dispelling wind and freeing orifices.

Description

A kind of medicine being used for the treatment of allergic rhinitis
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of allergic rhinitis.
Background technology
The pathogenic factors of allergic rhinitis is comparatively complicated, and the increase life stress increase etc. that the change etc. of hereditary ethnic allergen air pollutants life style and dietary habit all can bring out allergic rhinitis pungent smoking touch opportunity is all likely that its correlative factor of reason increasing the weight of allergic disease need further exploration.
The medicine of current western medical treatment allergic rhinitis has antihistaminic, glucocorticoid, shoulders the medicine such as leukotriene medicine, chromone class.But all belong to symptomatic treatment, can not eradicate and also easily occur untoward reaction.Extreme influence is caused to the life of patient and body and mind.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aim to provide a kind of be used for the treatment of allergic rhinitis medicine, by selecting suitable medical material and proportioning thereof, reaching the object of safe and effective healing allergic rhinitis.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of be used for the treatment of allergic rhinitis medicine, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Fructus Xanthii 5 parts, Radix Saposhnikoviae 4 parts, the Rhizoma Atractylodis Macrocephalae 5 parts, Herba Oxalidis Corniculatae 3 parts, Radix Rhodiolae 2 parts, Herba Menthae 4 parts, Radix Ilicis Asprellae 3 parts, Exocarpium Citri Grandis 5 parts, Cortex Lycii 2 parts.
Inventor thinks: the trouble multi-source lungs of nose.Pulmonary has illness then to breathe to have some setbacks water channel not smooth.Another deficiency of spleen-QI, heresy be stagnant nose key also.So only have lung spleen to rule together, benefiting QI for strengthening the superficies, dispelling wind is sensible can cure this disease.
The present invention uses: Fructus Xanthii powder wind dehumidifies, clearing the nasal passage; Wind-proof wind, relieving exterior syndrome; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic; The eliminating pathogen in the liver of Herba Oxalidis Corniculatae tonifying the lung, heat extraction QI and blood; Radix Rhodiolae promoting blood circulation and hemostasis, clearing away lung-heat to relieve cough; Herba Menthae wards off dirty removing toxic substances; Radix Ilicis Asprellae promoting the production of body fluid to quench thirst; Exocarpium Citri Grandis cold expelling dampness; Cortex Lycii lung heat clearing pathogenic fire reducing.All medicines share, play benefiting QI for strengthening the superficies altogether, effect that dispelling wind is sensible, effective treatment of allergic rhinitis.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects Allergic Rhinitis 80 example for 2012 altogether between year December of December ~ 2014, all from Pneumology Department outpatient service, at 20 ~ 60 years old age, man 67 is routine, female 13 example.The course of disease 1 year ~ 6 years.
Diagnostic criteria: 1. perennial onset, has sneeze (at every turn continuous more than 3), snivel and tunica mucosa nasi swelling 3 main clinical manifestation, and number of days of falling ill in 1 year is accumulative more than 6 months, and in 1 day, disease time added up 0.5h; 2. the common nasal mucosa of sign pale edema nasal cavity watery secretion.3. the course of disease at least 1 year.
Meet above-mentioned diagnostic criteria, patient that the age is greater than 18 years old.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Hepatic and renal function is abnormal or with serious primary disease etc.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.4 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " the sick efficacy assessment standard of allergic rhinitis ".
(1) cure: after treatment, patient frequently does without paroxysmal sneeze, have a stuffy nose, flows a large amount of thin nasal discharge, nasal mucosa is edema sample, concha nasalis enlargement disappears;
(2) effective: after treatment, patient's clinical symptoms disappears substantially, and under asoscope, mucosa is without obvious edema and secretions, but still has recurrence in 1 week;
(3) effective: the rear patient's paroxysmal sneeze for the treatment of is done frequently, have a stuffy nose, flow a large amount of thin nasal discharge, nasal mucosa is edema sample, concha nasalis enlargement obviously alleviates;
(4) invalid: after treatment, patient's clinical symptoms and sign are not improved.
3.2 therapeutic outcome
80 routine patients cure 52 examples, and effective 12, effective 3 examples, invalid 3 examples.Total effective rate 97.5%.Treatments period has no other obvious adverse reaction.Visible the present invention be used for the treatment of allergic rhinitis safe and effective, there is the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Fructus Xanthii 5 grams, Radix Saposhnikoviae 4 grams, the Rhizoma Atractylodis Macrocephalae 5 grams, Herba Oxalidis Corniculatae 3 grams, Radix Rhodiolae 2 grams, Herba Menthae 4 grams, Radix Ilicis Asprellae 3 grams, Exocarpium Citri Grandis 5 grams, Cortex Lycii 2 grams; Add 8 times of water gagings, decoct 1.5 hours, filtration; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of allergic rhinitis.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Fructus Xanthii 5 grams, Radix Saposhnikoviae 4 grams, the Rhizoma Atractylodis Macrocephalae 5 grams, Herba Oxalidis Corniculatae 3 grams, Radix Rhodiolae 2 grams, Herba Menthae 4 grams, Radix Ilicis Asprellae 3 grams, Exocarpium Citri Grandis 5 grams, Cortex Lycii 2 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of allergic rhinitis.Oral, daily once.
Embodiment 3
Take: Fructus Xanthii 5 grams, Radix Saposhnikoviae 4 grams, the Rhizoma Atractylodis Macrocephalae 5 grams, Herba Oxalidis Corniculatae 3 grams, Radix Rhodiolae 2 grams, Herba Menthae 4 grams, Radix Ilicis Asprellae 3 grams, Exocarpium Citri Grandis 5 grams, Cortex Lycii 2 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of allergic rhinitis.Oral, every bu is taken for twice sooner or later.

Claims (4)

1. one kind is used for the treatment of the medicine of allergic rhinitis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Fructus Xanthii 5 parts, Radix Saposhnikoviae 4 parts, the Rhizoma Atractylodis Macrocephalae 5 parts, Herba Oxalidis Corniculatae 3 parts, Radix Rhodiolae 2 parts, Herba Menthae 4 parts, Radix Ilicis Asprellae 3 parts, Exocarpium Citri Grandis 5 parts, Cortex Lycii 2 parts.
2. be used for the treatment of the medicine of allergic rhinitis as claimed in claim 1, it is characterized in that, its preparation method is: take: Fructus Xanthii 5 parts, Radix Saposhnikoviae 4 parts, the Rhizoma Atractylodis Macrocephalae 5 parts, Herba Oxalidis Corniculatae 3 parts, Radix Rhodiolae 2 parts, Herba Menthae 4 parts, Radix Ilicis Asprellae 3 parts, Exocarpium Citri Grandis 5 parts, Cortex Lycii 2 parts; Add 8 times of water gagings, decoct 1.5 hours, filtration; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of the medicine of allergic rhinitis as claimed in claim 1, it is characterized in that, its preparation method is: take: Fructus Xanthii 5 parts, Radix Saposhnikoviae 4 parts, the Rhizoma Atractylodis Macrocephalae 5 parts, Herba Oxalidis Corniculatae 3 parts, Radix Rhodiolae 2 parts, Herba Menthae 4 parts, Radix Ilicis Asprellae 3 parts, Exocarpium Citri Grandis 5 parts, Cortex Lycii 2 parts; Add 10 times of water gagings, decoct 2 hours, filtration; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filtration; Merging filtrate, concentrated, dry, packaging, namely obtain powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of the medicine of allergic rhinitis as claimed in claim 1, it is characterized in that, its preparation method is: take: Fructus Xanthii 5 parts, Radix Saposhnikoviae 4 parts, the Rhizoma Atractylodis Macrocephalae 5 parts, Herba Oxalidis Corniculatae 3 parts, Radix Rhodiolae 2 parts, Herba Menthae 4 parts, Radix Ilicis Asprellae 3 parts, Exocarpium Citri Grandis 5 parts, Cortex Lycii 2 parts; Add 6 times of water gagings, decoct 3 times, each to decoct 1 hour, merge decoction liquor, concentrated, dry, incapsulate shell, namely obtain capsule; Above-mentioned part all refers to weight portion.
CN201510807822.5A 2015-11-19 2015-11-19 Drug for treating allergic rhinitis Pending CN105267436A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510807822.5A CN105267436A (en) 2015-11-19 2015-11-19 Drug for treating allergic rhinitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510807822.5A CN105267436A (en) 2015-11-19 2015-11-19 Drug for treating allergic rhinitis

Publications (1)

Publication Number Publication Date
CN105267436A true CN105267436A (en) 2016-01-27

Family

ID=55137829

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510807822.5A Pending CN105267436A (en) 2015-11-19 2015-11-19 Drug for treating allergic rhinitis

Country Status (1)

Country Link
CN (1) CN105267436A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103610788A (en) * 2013-11-13 2014-03-05 王震 Traditional Chinese medicine (TCM) for treating allergic rhinitis
CN104435104A (en) * 2013-09-22 2015-03-25 李少洋 Formula of traditional Chinese medicine for treating allergic rhinitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435104A (en) * 2013-09-22 2015-03-25 李少洋 Formula of traditional Chinese medicine for treating allergic rhinitis
CN103610788A (en) * 2013-11-13 2014-03-05 王震 Traditional Chinese medicine (TCM) for treating allergic rhinitis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张磊等: "过敏性鼻炎治验", 《实用中医内科杂志》 *
秦晓晨等: "中药超声雾化吸入治疗过敏性鼻炎50例", 《河南医科大学学报》 *

Similar Documents

Publication Publication Date Title
CN101095736B (en) Chinese traditional medicine composition for treating acute and chronic pharyngitis, tonsillitis and method of making the same
CN102813702A (en) Lotion for treating rhinitis
CN101537089A (en) Pharmaceutical composition for curing allergic rhinitis and preparation method thereof
CN104042814A (en) Traditional Chinese medicinal composition for treating anaphylactic rhinitis
CN100409882C (en) Heat clearing and detoxicating drug for abating fever
CN101637546B (en) Medicine for treating acute and chronic rhinitis and sinusitis
CN104173950B (en) A kind of herbal composite for treating prostate cancer
CN103432222A (en) Medicine for treating allergic rhinitis
CN104800382A (en) Traditional Chinese medicine composition for treating colds, as well as preparation method and application thereof
CN102772650B (en) Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof
CN104840734B (en) Clearing health-care Chinese medicinal composition and its preparation method and application
CN101138613A (en) Chinese traditional medicine for treating acute bronchitis of children
CN102949526A (en) Healthcare particles for treating chronic pharyngitis and preparation method thereof
CN106539908A (en) A kind of Chinese medicine composition for treating allergic rhinitises and skin allergy
CN105169001B (en) A kind of Chinese medicine composition for treating cough variant asthma in childhood: prednison comparing
CN105267436A (en) Drug for treating allergic rhinitis
CN106581256A (en) Traditional Chinese medicinal composition for treating nasosinusitis, medicinal preparation for treating nasosinusitis, and preparation method of medicinal preparation
CN105250771A (en) Traditional Chinese medicine oral solution for treating chronic pharyngitis and preparation method of traditional Chinese medicine oral solution
CN105250968A (en) Traditional Chinese medicine preparation for treating asthma
CN102885958B (en) Medicament for treating chronic pharyngitis
CN103638449B (en) A kind of Chinese medicine for the treatment of equus sinusitis
CN102688354B (en) Traditional Chinese medicine decoction of schizonepeta for treating cough and preparation method thereof
CN103800860A (en) Medicine for treating wind-cold type common cold and preparation method thereof
CN105362548A (en) Traditional Chinese medicine for treating allergic asthma
CN111773365A (en) Traditional Chinese medicine composition for treating rhinitis and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160127